SMD Rise PCLBKK:SMD100-R 59 Earnings Yield (Joel Greenblatt) % is 5.62% as of Mar. 2026, which is 34% below its 10-year median of 8.46. GuruFocus rates BKK:SMD100-R with a GF Score™ of 59/100 and a GF Value™ of ฿22.94. The stock has 6 warning signs investors should review. Among 120 Medical Distribution companies, SMD Rise PCL ranks better than 55.83% on this metric.
SMD Rise PCL's Enterprise Value for the quarter that ended in Mar. 2026 was ฿1,437.3 Mil.
SMD Rise PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ฿32.9 Mil. SMD Rise PCL's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 5.62%.
The historical rank and industry rank for SMD Rise PCL's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
BKK:SMD100-R'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 3.53 Med: 8.46 Max: 30.86
Current: 7.18
During the past 8 years, the highest Earnings Yield (Joel Greenblatt) of SMD Rise PCL was 30.86%. The lowest was 3.53%. And the median was 8.46%.
BKK:SMD100-R's Earnings Yield (Joel Greenblatt) % is ranked better than 55.83% of 120
companies
in the Medical Distribution industry
Industry Median: 6.435
vs BKK:SMD100-R: 7.18
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. SMD Rise PCL's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was -10.75%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
SMD Rise PCL Earnings Yield (Joel Greenblatt) % Related Terms
SMD Rise PCL Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, SMD Rise PCL's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL Earnings Yield (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
SMD Rise PCLs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
SMD Rise PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿32.9 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 5.62% mean?
SMD Rise PCL (BKK:SMD100-R) has a Earnings Yield (Joel Greenblatt) % of 5.62% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on SMD Rise PCL and its competitors. This is 34% below median its historical median of 8.46. Over the past decade, SMD Rise PCL's Earnings Yield (Joel Greenblatt) % has ranged from 3.53 to 30.86. According to the industry distribution chart, SMD Rise PCL ranks #53 out of 120 companies in the Medical Distribution industry, placing it in the top 44.2%.
Is SMD Rise PCL's Earnings Yield (Joel Greenblatt) % too high?
SMD Rise PCL's current Earnings Yield (Joel Greenblatt) % of 5.62% is 34% below median its 10-year median of 8.46. Over the past 10 years, this metric has ranged from a low of 3.53 to a high of 30.86. The Medical Distribution industry median Earnings Yield (Joel Greenblatt) % is 6.44. SMD Rise PCL's value of 5.62% is 12.7% below this industry median. Based on the distribution chart, SMD Rise PCL ranks #53 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's Earnings Yield (Joel Greenblatt) % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #53 out of 120 companies for Earnings Yield (Joel Greenblatt) %. This puts SMD Rise PCL in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 6.44. SMD Rise PCL's value of 5.62% is 12.7% below this benchmark. Historically, SMD Rise PCL's own Earnings Yield (Joel Greenblatt) % has ranged from 3.53 to 30.86 over the past decade. While the company's 10-year median is 8.46 vs. the industry median of 6.44, SMD Rise PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Distribution company?
The median Earnings Yield (Joel Greenblatt) % among Medical Distribution companies is 6.44, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMD Rise PCL's current Earnings Yield (Joel Greenblatt) % of 5.62% is 12.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median Earnings Yield (Joel Greenblatt) % is 6.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current Earnings Yield (Joel Greenblatt) % is 5.62%, which is 34% below median its own 10-year median of 8.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current Earnings Yield (Joel Greenblatt) % of 5.62%. The stock's GF Value™ is ฿22.94, compared to a current price of ฿5.85 — trading 74.5% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 5.62%, which is 34% below median its 10-year median of 8.46 and 12.7% below the Medical Distribution industry median of 6.44. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current Earnings Yield (Joel Greenblatt) % is 5.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 74.5% below its estimated GF Value™ of ฿22.94.
Key valuation signals for BKK:SMD100-R:
Earnings Yield (Joel Greenblatt) %: 5.62% (34% below median its 10-year median of 8.46)
GF Value™: ฿22.94 vs. price of ฿5.85 (74.5% below fair value)
Industry Position: 12.7% below the Medical Distribution median (#53 of 120)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
